MARTIN, L. J.; ALIBHAI, S. M.; KOMISARENKO, M.; TIMILSHINA, N.; FINELLI, A. Identification of subgroups of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone plus prednisone at low- vs. high-risk of radiographic progression: An analysis of COU-AA-302. Canadian Urological Association Journal, [S. l.], v. 13, n. 6, 2018. DOI: 10.5489/cuaj.5586. Disponível em: https://cuaj.ca/index.php/journal/article/view/5586. Acesso em: 26 apr. 2024.